Shares of Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.26 and traded as low as $0.2480. Northwest Biotherapeutics shares last traded at $0.2530, with a volume of 3,587,255 shares changing hands.
Northwest Biotherapeutics Stock Performance
The firm’s 50-day moving average is $0.25 and its 200 day moving average is $0.26. The stock has a market cap of $386.82 million, a PE ratio of -4.22 and a beta of -0.70.
Northwest Biotherapeutics (OTCMKTS:NWBO – Get Free Report) last released its quarterly earnings results on Thursday, August 14th. The biotechnology company reported ($0.01) EPS for the quarter. The company had revenue of $0.13 million for the quarter.
About Northwest Biotherapeutics
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Featured Stories
- Five stocks we like better than Northwest Biotherapeutics
- What does consumer price index measure?
- The Drone Arms Race: From Battlefield to Balance Sheet
- The How And Why of Investing in Oil Stocks
- Why Wall Street Is Backing These 3 Comeback Stocks
- Short Selling – The Pros and Cons
- Intel’s Breakout Quarter: More Than a Beat, It’s a Declaration
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
